Nektar Therapeutics · NASDAQ:NKTR

Brainard Diana received 2,000 Nektar Therapeutics shares as an award (Form 4)

Traded Sep 23, 2026 · Filed Sep 25, 2026

On Sep 23, 2026, Brainard Diana (Director) received 2,000 Nektar Therapeutics shares as an award, leaving 3,904 shares. Filed Sep 25, 2026 (Form 4).

Awarded
2,000 shares
Holding after
3,904 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 23, 2026Common StockAward2,0003,904Direct

Source

View original at SEC

Related